M.marinum lacking epsH shows increased biofilm formation in vitro and boosted antibiotic tolerance in zebrafish

  • 1Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
  • 2Laboratory of Microbiology, Parasitology and Hygiene (LMPH), Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, University of Antwerp, Wilrijk, 2000, Antwerp, Belgium.
  • 3Department of Food Science, Faculty of Science, University of Copenhagen, Rolighedsvej 26, 1958, Frederiksberg C, Denmark.
  • 4Faculty of Pharmacy, Division of Pharmaceutical Chemistry and Technology, University of Helsinki, Helsinki, Finland.
  • 5Faculty of Agriculture and Forestry, FI-00014, University of Helsinki, Helsinki, Finland.
  • 6Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland. milka.vuoksio@gmail.com.
  • 7European Molecular Biology Laboratory, Heidelberg, Germany. milka.vuoksio@gmail.com.

Abstract

Recent discoveries have indicated that biofilm communities may play a role in natural drug tolerance of Mycobacterium tuberculosis. A transposon-based mutation library of a closely related species, Mycobacterium marinum, was used to identify clones in which the relative amount of extracellular DNA (eDNA), an important component of the extracellular matrix of biofilms, is altered. The disruption of a putative glycosyl transferase gene QDR78 11175, epsH, caused a substantial increase of the eDNA content of biofilms, and increased the growth rate and the biomass/cell in biofilm-forming conditions compared to wild-type. The increased abundance of biomass was mainly due to the elevated levels of eDNA and proteins in the extracellular matrix. The growth of the ΔepsH strain in the zebrafish was normal, but the mutant developed greater antibiotic tolerance in the adult zebrafish model. These results suggest that the extracellular matrix of biofilms increases antibiotic tolerance of mycobacteria during infection.

Related Concept Videos